Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies

BACKGROUND: Liquid rebiopsies can detect resistance mutations to guide therapy of anaplastic lymphoma kinase-rearranged (ALK(+)) non-small-cell lung cancer (NSCLC) failing tyrosine kinase inhibitors (TKI). Here, we analyze how their results relate to the anatomical pattern of disease progression and...

Descripción completa

Detalles Bibliográficos
Autores principales: Christopoulos, Petros, Dietz, Steffen, Angeles, Arlou K., Rheinheimer, Stephan, Kazdal, Daniel, Volckmar, Anna-Lena, Janke, Florian, Endris, Volker, Meister, Michael, Kriegsmann, Mark, Zemojtel, Thomasz, Reck, Martin, Stenzinger, Albrecht, Thomas, Michael, Sültmann, Holger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182700/
https://www.ncbi.nlm.nih.gov/pubmed/34164264
http://dx.doi.org/10.21037/tlcr-21-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182700/
https://www.ncbi.nlm.nih.gov/pubmed/34164264
http://dx.doi.org/10.21037/tlcr-21-32

Ejemplares similares